April 4th 2025, 7:00pm
CAR-T therapy for myeloma faces challenges in early-line use due to accessibility, eligibility criteria and long wait times, despite strong efficacy in trials.
March 27th 2025, 7:00pm
Dr. Cesar Rodriguez discussed treatment advancements for multiple myeloma during a CURE Educated Patient® Summit.
March 26th 2025, 7:00pm
A panel of experts discussed the transition of care between community and academic centers at the CURE Educated Patient Multiple Myeloma Summit.
August 29th 2024, 7:00pm
Patients with multiple myeloma now have several available treatment options, so it’s important to have answers to some of the frequently asked questions.
August 27th 2024, 7:22pm
Questions about multiple myeloma regarding treatment options, bone strength and other associated comorbidities were answered by an expert.
June 20th 2024, 6:00pm
During the CURE® Educated Patient® Multiple Myeloma Summit, one expert explained the push to make CAR-T cell therapy available for patients sooner.
June 14th 2024, 7:00pm
As part of the CURE® Educated Patient® Summit, one expert reviewed the landscape of bispecific antibodies, such as Tecvayli, for multiple myeloma.
June 13th 2024, 7:00pm
Quality of life may temporarily worsen after patients with myeloma receive stem cell transplants, said an expert at the Educated Patient® Multiple Myeloma Summit.
June 11th 2024, 7:23pm
New drug combinations and sequences are being investigated and may improve outcomes for patients with newly diagnosed myeloma, an expert explained at the Educated Patient® Multiple Myeloma Summit.
April 29th 2023, 3:00pm
Watch Dr. Brandon J Blue, Dr. Surbhi Sidana, Dr. Kenneth H. Shain and Mary Derome answer questions about the future of treatment during the CURE Educated Patient Multiple Myeloma Summit.
My Health, My Voice: Why Self-Advocacy Is Important
When a Thoughtless Mammogram Reminder Reopened a Deep Cancer Wound
A Lifelong Advocate and Innovator
Personalized Breast Cancer Care for Older Adults Goes Beyond Age